Genetic ablation of C5aR1 in the Arctic mouse model of AD results in a protection from cognitive decline and from loss of neuronal complexity in the CA129 and CA3 region of the hippocampus (Supp Figure S3) at 10 months of age. Here, C5AR1 is linked to Alzheimer disease.